McPherson's (ASX:MCP) said its McPherson's Consumer Products subsidiary entered into a pharmacy wholesaler agreement with Symbion for a three-year term starting on June 1, according to a Thursday Australian bourse filing.
Under the group's new operating model announced on Feb. 24, the current annual revenue of about AU$10 million to AU$15 million from retailers, previously serviced through the direct-to-store model, will now be serviced through its wholesale relationship with Symbion.
The company's shares were up nearly 1% in recent Thursday trade.
免責聲明：投資有風險，本文並非投資建議，以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請，作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考，不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證，投資者應自行研究並在投資前尋求專業建議。